Zosano Pharma Corp 4
Accession 0001181431-15-001720
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 1:32 PM ET
Size
22.9 KB
Accession
0001181431-15-001720
Insider Transaction Report
- Conversion
Common Stock
2015-01-30$9.35/sh+341,201$3,190,229→ 2,135,082 total - Conversion
8% Convertible Note Issued 12/2/2014
2015-01-30Exp: 2015-03-31→ Common Stock - Conversion
8% Convertible Note Issued 9/9/2013
2015-01-30Exp: 2015-03-31→ Common Stock - Conversion
8% Convertible Note Issued 2/26/14
2015-01-30Exp: 2015-03-31→ Common Stock - Purchase
Common Stock
2015-01-30$11.00/sh+23,457$258,027→ 2,158,539 total
- Conversion
Common Stock
2015-01-30$9.35/sh+341,201$3,190,229→ 2,135,082 total - Conversion
8% Convertible Note Issued 9/9/2013
2015-01-30Exp: 2015-03-31→ Common Stock - Conversion
8% Convertible Note Issued 2/26/14
2015-01-30Exp: 2015-03-31→ Common Stock - Conversion
8% Convertible Note Issued 12/2/2014
2015-01-30Exp: 2015-03-31→ Common Stock - Purchase
Common Stock
2015-01-30$11.00/sh+23,457$258,027→ 2,158,539 total
- Conversion
Common Stock
2015-01-30$9.35/sh+341,201$3,190,229→ 2,135,082 total - Conversion
8% Convertible Note Issued 9/9/2013
2015-01-30Exp: 2015-03-31→ Common Stock - Purchase
Common Stock
2015-01-30$11.00/sh+23,457$258,027→ 2,158,539 total - Conversion
8% Convertible Note Issued 2/26/14
2015-01-30Exp: 2015-03-31→ Common Stock - Conversion
8% Convertible Note Issued 12/2/2014
2015-01-30Exp: 2015-03-31→ Common Stock
- Conversion
Common Stock
2015-01-30$9.35/sh+341,201$3,190,229→ 2,135,082 total - Conversion
8% Convertible Note Issued 9/9/2013
2015-01-30Exp: 2015-03-31→ Common Stock - Purchase
Common Stock
2015-01-30$11.00/sh+23,457$258,027→ 2,158,539 total - Conversion
8% Convertible Note Issued 2/26/14
2015-01-30Exp: 2015-03-31→ Common Stock - Conversion
8% Convertible Note Issued 12/2/2014
2015-01-30Exp: 2015-03-31→ Common Stock
- Conversion
Common Stock
2015-01-30$9.35/sh+341,201$3,190,229→ 2,135,082 total - Conversion
8% Convertible Note Issued 9/9/2013
2015-01-30Exp: 2015-03-31→ Common Stock - Purchase
Common Stock
2015-01-30$11.00/sh+23,457$258,027→ 2,158,539 total - Conversion
8% Convertible Note Issued 2/26/14
2015-01-30Exp: 2015-03-31→ Common Stock - Conversion
8% Convertible Note Issued 12/2/2014
2015-01-30Exp: 2015-03-31→ Common Stock
- Conversion
8% Convertible Note Issued 9/9/2013
2015-01-30Exp: 2015-03-31→ Common Stock - Conversion
8% Convertible Note Issued 12/2/2014
2015-01-30Exp: 2015-03-31→ Common Stock - Purchase
Common Stock
2015-01-30$11.00/sh+23,457$258,027→ 2,158,539 total - Conversion
Common Stock
2015-01-30$9.35/sh+341,201$3,190,229→ 2,135,082 total - Conversion
8% Convertible Note Issued 2/26/14
2015-01-30Exp: 2015-03-31→ Common Stock
- Conversion
8% Convertible Note Issued 9/9/2013
2015-01-30Exp: 2015-03-31→ Common Stock - Conversion
Common Stock
2015-01-30$9.35/sh+341,201$3,190,229→ 2,135,082 total - Conversion
8% Convertible Note Issued 2/26/14
2015-01-30Exp: 2015-03-31→ Common Stock - Purchase
Common Stock
2015-01-30$11.00/sh+23,457$258,027→ 2,158,539 total - Conversion
8% Convertible Note Issued 12/2/2014
2015-01-30Exp: 2015-03-31→ Common Stock
- Conversion
8% Convertible Note Issued 9/9/2013
2015-01-30Exp: 2015-03-31→ Common Stock - Conversion
8% Convertible Note Issued 12/2/2014
2015-01-30Exp: 2015-03-31→ Common Stock - Conversion
Common Stock
2015-01-30$9.35/sh+341,201$3,190,229→ 2,135,082 total - Purchase
Common Stock
2015-01-30$11.00/sh+23,457$258,027→ 2,158,539 total - Conversion
8% Convertible Note Issued 2/26/14
2015-01-30Exp: 2015-03-31→ Common Stock
- Conversion
8% Convertible Note Issued 2/26/14
2015-01-30Exp: 2015-03-31→ Common Stock - Conversion
Common Stock
2015-01-30$9.35/sh+341,201$3,190,229→ 2,135,082 total - Purchase
Common Stock
2015-01-30$11.00/sh+23,457$258,027→ 2,158,539 total - Conversion
8% Convertible Note Issued 9/9/2013
2015-01-30Exp: 2015-03-31→ Common Stock - Conversion
8% Convertible Note Issued 12/2/2014
2015-01-30Exp: 2015-03-31→ Common Stock
Footnotes (2)
- [F1]The outstanding principal and accrued interest on the Convertible Notes automatically converted into shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering at 85% of the Issuer's initial public offering price per share.
- [F2]The securities are directly held by New Enterprise Associates 12, Limited Partnership ("NEA 12") and indirectly held by NEA Partners 12, Limited Partnership ("NEA Partners 12"), the sole general partner of NEA 12, NEA 12 GP, LLC ("NEA 12 GP"), the sole general partner of NEA Partners 12, and the individual managers of NEA 12 GP (NEA Partners 12, NEA 12 GP and the individual managers of NEA 12 GP together, the "NEA 12 Indirect Reporting Persons"). The individual managers of NEA 12 GP are M. James Barrett, Peter J. Barris, Forest Baskett, Ryan D. Drant, Patrick J. Kerins, Krishna "Kittu" Kolluri, and Scott D. Sandell. The NEA 12 Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 12 shares in which the NEA 12 Indirect Reporting Persons have no pecuniary interest.
Documents
Issuer
Zosano Pharma Corp
CIK 0001587221
Related Parties
1- filerCIK 0001587221
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 1:32 PM ET
- Size
- 22.9 KB